{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Treatment+Effectiveness&page=2", "query": { "condition": "Treatment Effectiveness", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Treatment+Effectiveness&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-22T08:59:29.471Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05067283", "title": "A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumors" ], "interventions": [ { "name": "Calderasib", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "carboplatin", "type": "DRUG" }, { "name": "pemetrexed", "type": "DRUG" }, { "name": "cetuximab", "type": "BIOLOGICAL" }, { "name": "oxaliplatin", "type": "DRUG" }, { "name": "leucovorin", "type": "DRUG" }, { "name": "5-fluorouracil", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 830, "start_date": "2021-12-17", "completion_date": "2030-02-25", "has_results": false, "last_update_posted_date": "2026-09-14", "last_synced_at": "2026-09-22T08:59:29.471Z", "location_count": 6, "location_summary": "Tampa, Florida • Grand Rapids, Michigan • Hackensack, New Jersey + 3 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Grand Rapids", "state": "Michigan" }, { "city": "Hackensack", "state": "New Jersey" }, { "city": "New York", "state": "New York" }, { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05067283" }, { "nct_id": "NCT01120132", "title": "Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Allergic Conjunctivitis" ], "interventions": [ { "name": "CsA high dose", "type": "DRUG" }, { "name": "CsA low dose", "type": "DRUG" }, { "name": "PA", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fovea Pharmaceuticals SA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 716, "start_date": "2010-05", "completion_date": "2010-08", "has_results": false, "last_update_posted_date": "2012-03-09", "last_synced_at": "2026-09-22T08:59:29.471Z", "location_count": 1, "location_summary": "Andover, Massachusetts", "locations": [ { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01120132" }, { "nct_id": "NCT00158132", "title": "Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cocaine-Related Disorders" ], "interventions": [ { "name": "Propranolol", "type": "DRUG" }, { "name": "Amantadine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 199, "start_date": "1999-09", "completion_date": "2006-02", "has_results": false, "last_update_posted_date": "2017-01-12", "last_synced_at": "2026-09-22T08:59:29.471Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00158132" }, { "nct_id": "NCT04372121", "title": "Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Endometriosis" ], "interventions": [ { "name": "75 mg linzagolix tablet", "type": "DRUG" }, { "name": "200 mg linzagolix tablet", "type": "DRUG" }, { "name": "Add-back capsule (E2 1 mg / NETA 0.5 mg)", "type": "DRUG" }, { "name": "Placebo tablet to match 75 mg linzagolix tablet", "type": "DRUG" }, { "name": "Placebo tablet to match 200 mg linzagolix tablet", "type": "DRUG" }, { "name": "Placebo capsule to match Add-back capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kissei Pharmaceutical Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 30, "start_date": "2020-03-23", "completion_date": "2021-02-16", "has_results": true, "last_update_posted_date": "2025-04-02", "last_synced_at": "2026-09-22T08:59:29.471Z", "location_count": 23, "location_summary": "Little Rock, Arkansas • Norwalk, California • Greenwood Village, Colorado + 17 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Norwalk", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Lakewood", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04372121" }, { "nct_id": "NCT04927572", "title": "Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "FMX114", "type": "DRUG" }, { "name": "Vehicle", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Vyne Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 21, "start_date": "2021-10-13", "completion_date": "2022-08-09", "has_results": false, "last_update_posted_date": "2022-08-31", "last_synced_at": "2026-09-22T08:59:29.471Z", "location_count": 4, "location_summary": "Miami, Florida • Miramar, Florida • Sugarloaf, Pennsylvania", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miramar", "state": "Florida" }, { "city": "Sugarloaf", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04927572" }, { "nct_id": "NCT05774639", "title": "Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Idiopathic Urticaria" ], "interventions": [ { "name": "Omalizumab Injection", "type": "DRUG" }, { "name": "Xolair Prefilled Syringe", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kashiv BioSciences, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 600, "start_date": "2023-08-15", "completion_date": "2024-12-31", "has_results": false, "last_update_posted_date": "2025-02-05", "last_synced_at": "2026-09-22T08:59:29.471Z", "location_count": 4, "location_summary": "Brandon, Florida • Brooksville, Florida • Miami Lakes, Florida + 1 more", "locations": [ { "city": "Brandon", "state": "Florida" }, { "city": "Brooksville", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" }, { "city": "West Lafayette", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05774639" }, { "nct_id": "NCT01945593", "title": "BAX 855 Continuation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hemophilia A" ], "interventions": [ { "name": "BAX855", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Baxalta now part of Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "75 Years", "sex": "ALL", "summary": "Up to 75 Years" }, "enrollment_count": 218, "start_date": "2013-10-15", "completion_date": "2018-03-02", "has_results": true, "last_update_posted_date": "2021-05-24", "last_synced_at": "2026-09-22T08:59:29.471Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Aurora, Colorado • Gainesville, Florida + 18 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Peoria", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01945593" }, { "nct_id": "NCT01431287", "title": "Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "tiotropium + olodaterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "olodaterol", "type": "DRUG" }, { "name": "Respimat", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 2539, "start_date": "2011-09", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-07-16", "last_synced_at": "2026-09-22T08:59:29.471Z", "location_count": 38, "location_summary": "Greer, California • Fort Collins, Colorado • Danbury, Connecticut + 32 more", "locations": [ { "city": "Greer", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Danbury", "state": "Connecticut" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01431287" }, { "nct_id": "NCT00347893", "title": "The Efficacy of Selective Laser Trabeculoplasty", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Primary Open Angle Glaucoma", "Ocular Hypertension", "Pseudo-Exfoliative Glaucoma", "Pigment Dispersion Glaucoma" ], "interventions": [ { "name": "Selective laser trabeculoplasty", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Glaucoma Research & Education Group", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "0 Years", "maximum_age": null, "sex": "ALL", "summary": "0 Years and older" }, "enrollment_count": null, "start_date": "2006-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2006-07-04", "last_synced_at": "2026-09-22T08:59:29.471Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00347893" }, { "nct_id": "NCT02006290", "title": "Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Parkinson's Disease" ], "interventions": [ { "name": "PF-06412562", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "30 Years to 75 Years" }, "enrollment_count": 19, "start_date": "2014-03", "completion_date": "2014-08", "has_results": false, "last_update_posted_date": "2015-10-02", "last_synced_at": "2026-09-22T08:59:29.471Z", "location_count": 5, "location_summary": "Aventura, Florida • Baco Raton, Florida • South Miami, Florida + 2 more", "locations": [ { "city": "Aventura", "state": "Florida" }, { "city": "Baco Raton", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Bingham Farms", "state": "Michigan" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02006290" } ] }